Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: Expression profiling of circulating tumor cells in metastatic breast cancer.

Authors: Lang, Julie E; Scott, Janet H; Wolf, Denise M; Novak, Petr; Punj, Vasu; Magbanua, Mark Jesus M; Zhu, Weizhu; Mineyev, Neal; Haqq, Christopher M; Crothers, Julia R; Esserman, Laura J; Tripathy, Debasish; van 't Veer, Laura; Park, John W

Published In Breast Cancer Res Treat, (2015 Jan)

Abstract: Circulating tumor cells (CTCs) are prognostic in all stages of breast cancer. However, since they are extremely rare, little is known about the molecular nature of these cells. We report a novel strategy for the isolation and expression profiling of pure populations of CTCs derived from peripheral blood. We developed a method to isolate CTCs based on immunomagnetic capture followed by fluorescence-activated cell sorting (IE/FACS). After assay validation using the BT474 cell line spiked into blood samples in vitro, RNA from CTCs isolated from the blood of five metastatic breast cancer (MBC) patients was linearly amplified and subjected to gene expression profiling via cDNA microarrays. We isolated a range of 9-993 captured CTCs from five MBC patients' blood and profiled their RNA in comparison to a diverse panel of primary breast tumors (n = 55). Unsupervised hierarchical clustering revealed that CTC profiles clustered with more aggressive subtypes of primary breast tumors and were readily distinguishable from peripheral blood (PB) and normal epithelium. Differential expression analysis revealed CTCs to have downregulated apoptosis, and they were distinguishable from PB by the relative absence of immune-related signals. As expected, CTCs from MBC had significantly higher risk of recurrence scores than primary tumors (p = 0.0073). This study demonstrates that it is feasible to isolate CTCs from PB with high purity through IE/FACS and profile them via gene expression analysis. Our approach may inform the discovery of therapeutic predictors and be useful for real-time identification of emerging resistance mechanisms in MBC patients.

PubMed ID: 25432738 Exiting the NIEHS site

MeSH Terms: Antigens, Neoplasm/biosynthesis; Biomarkers, Tumor/blood*; Biosynthetic Pathways/genetics; Breast Neoplasms/blood; Breast Neoplasms/genetics*; Breast Neoplasms/pathology; Cell Adhesion Molecules/biosynthesis; Epithelial Cell Adhesion Molecule; Female; Flow Cytometry; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Microarray Analysis; Middle Aged; Neoplasm Metastasis; Neoplasm Proteins/biosynthesis; Neoplasm Proteins/blood; Neoplasm Recurrence, Local/genetics*; Neoplasm Recurrence, Local/pathology; Neoplastic Cells, Circulating*; Prognosis

Back
to Top